FDA expands use for FilmArray Respiratory Panel
date:May 16, 2012
ct, additional testing for a suspected respiratory infection may be necessary. The test does not detect all causes of respiratory infection.

Performance of the multiplex panel was determined by studying the test in 1,117 patients with suspected respiratory infections and 467 samples from patients with documented infections.

Molecular-based testing identifies micro-organisms, such as viruses and bacteria, by detecting the presence of their genetic material. For certain viruses and bacteria, mol
4/5 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
05/08 04:53